Thorne Healthtech Inc
NASDAQ:THRN
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
T
|
Thorne Healthtech Inc
NASDAQ:THRN
|
549.4m USD | 28.4 | |
FR |
L'Oreal SA
PAR:OR
|
243.6B EUR | 26.1 | ||
UK |
Unilever PLC
LSE:ULVR
|
107.9B GBP | 198.1 | ||
IN |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR | 36.9 | ||
US |
Estee Lauder Companies Inc
NYSE:EL
|
48.3B USD | 24.9 | ||
UK |
HALEON PLC
LSE:HLN
|
30.3B GBP | 13 | ||
DE |
Beiersdorf AG
XETRA:BEI
|
33.3B EUR | 17.2 | ||
JP |
Kao Corp
TSE:4452
|
3.2T JPY | 17.8 | ||
IN |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.4T INR | 45.1 | ||
JP |
Shiseido Co Ltd
TSE:4911
|
1.9T JPY | 20.7 | ||
IN |
Dabur India Ltd
NSE:DABUR
|
974.9B INR | 41.4 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.